Several clinical studies, including Phase 2 and 3 trials, have focused on evaluating the efficacy of various topical formulations in lowering IOP in adults with OHT or POAG, comparing them to existing therapies like latanoprost and timolol (NCT01917383, NCT02565173)
By the first nine months of 2023, approximately half of members prescribed a GLP-1 had a previous diagnosis of diabetes, a significant shift from 2018 when over 90% of members had a history of that diagnosis
Endoproteolysis of glucagon-like peptide (GLP)-1 (736) amide by ectopeptidases in RINm5F cells
Separatamente, utile sapere che il GHK-Cu anche un componente dei complessi rigenerativi GLOW50 / GLOW70 (con BPC-157 e TB-500)
Future research should aim to harmonize differentiation protocols, stem cell sources, and treatment concentrations to better define the therapeutic window and mechanisms of GLP-1-RA in regenerative applications
10.1016/j.molmet.2017.06.021 146 TurjemanS.RozeraT.ElinavE.IaniroG.KorenO
